Chlorothiazide sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorothiazide sodium and what is the scope of freedom to operate?
Chlorothiazide sodium
is the generic ingredient in two branded drugs marketed by Am Regent, Fresenius Kabi Usa, Gland Pharma Ltd, Rk Pharma, Sagent Pharms Inc, Sun Pharm, and Rising, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for chlorothiazide sodium. Five suppliers are listed for this compound.
Summary for chlorothiazide sodium
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 7 |
NDAs: | 7 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 4 |
Patent Applications: | 24 |
What excipients (inactive ingredients) are in chlorothiazide sodium? | chlorothiazide sodium excipients list |
DailyMed Link: | chlorothiazide sodium at DailyMed |
Recent Clinical Trials for chlorothiazide sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vanderbilt University | Phase 4 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
Yale University | Phase 1 |
Pharmacology for chlorothiazide sodium
Drug Class | Thiazide Diuretic |
Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for chlorothiazide sodium
US Patents and Regulatory Information for chlorothiazide sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rk Pharma | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202493-001 | Jun 18, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sun Pharm | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 091546-001 | Jul 26, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 090896-001 | Oct 16, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.